The role of donor-specific HLA alloantibodies in liver transplantation.
The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantib...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Blackwell Publishing Ltd
2014
|
| _version_ | 1797064310346743808 |
|---|---|
| author | O'Leary, J Demetris, A Friedman, L Gebel, H Halloran, P Kirk, A Knechtle, S McDiarmid, S Shaked, A Terasaki, P Tinckam, K Tomlanovich, S Wood, K Woodle, E Zachary, A Klintmalm, G |
| author_facet | O'Leary, J Demetris, A Friedman, L Gebel, H Halloran, P Kirk, A Knechtle, S McDiarmid, S Shaked, A Terasaki, P Tinckam, K Tomlanovich, S Wood, K Woodle, E Zachary, A Klintmalm, G |
| author_sort | O'Leary, J |
| collection | OXFORD |
| description | The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies. |
| first_indexed | 2024-03-06T21:12:26Z |
| format | Journal article |
| id | oxford-uuid:3ea34e6a-fba3-4b48-8ef0-7379ad8caf17 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:12:26Z |
| publishDate | 2014 |
| publisher | Blackwell Publishing Ltd |
| record_format | dspace |
| spelling | oxford-uuid:3ea34e6a-fba3-4b48-8ef0-7379ad8caf172022-03-26T14:26:46ZThe role of donor-specific HLA alloantibodies in liver transplantation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3ea34e6a-fba3-4b48-8ef0-7379ad8caf17EnglishSymplectic Elements at OxfordBlackwell Publishing Ltd2014O'Leary, JDemetris, AFriedman, LGebel, HHalloran, PKirk, AKnechtle, SMcDiarmid, SShaked, ATerasaki, PTinckam, KTomlanovich, SWood, KWoodle, EZachary, AKlintmalm, GThe impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt clinical injury, and that liver allografts possess some degree of alloantibody resistance, alloantibody-mediated adverse consequences are increasingly being recognized. To better define the current state of this topic, we assembled experts to provide insights, explore controversies and develop recommendations for future research on the consequences of DSA in liver transplantation. This article summarizes the proceedings of this inaugural meeting. Several insights emerged. Acute antibody-mediated rejection (AMR), although rarely diagnosed, is increasingly understood to overlap with T cell-mediated rejection. Isolated liver allograft recipients are at increased risk of early allograft immunologic injury when preformed DSA are high titer and persist posttransplantation. Persons who undergo simultaneous liver-kidney transplantation are at risk of renal AMR when Class II DSA persist posttransplantation. Other under-appreciated DSA associations include ductopenia and fibrosis, plasma cell hepatitis, biliary strictures and accelerated fibrosis associated with recurrent liver disease. Standardized DSA testing and diagnostic criteria for both acute and chronic AMR are needed to distil existing associations into etiological processes in order to develop responsive therapeutic strategies. |
| spellingShingle | O'Leary, J Demetris, A Friedman, L Gebel, H Halloran, P Kirk, A Knechtle, S McDiarmid, S Shaked, A Terasaki, P Tinckam, K Tomlanovich, S Wood, K Woodle, E Zachary, A Klintmalm, G The role of donor-specific HLA alloantibodies in liver transplantation. |
| title | The role of donor-specific HLA alloantibodies in liver transplantation. |
| title_full | The role of donor-specific HLA alloantibodies in liver transplantation. |
| title_fullStr | The role of donor-specific HLA alloantibodies in liver transplantation. |
| title_full_unstemmed | The role of donor-specific HLA alloantibodies in liver transplantation. |
| title_short | The role of donor-specific HLA alloantibodies in liver transplantation. |
| title_sort | role of donor specific hla alloantibodies in liver transplantation |
| work_keys_str_mv | AT olearyj theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT demetrisa theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT friedmanl theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT gebelh theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT halloranp theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT kirka theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT knechtles theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT mcdiarmids theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT shakeda theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT terasakip theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT tinckamk theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT tomlanovichs theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT woodk theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT woodlee theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT zacharya theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT klintmalmg theroleofdonorspecifichlaalloantibodiesinlivertransplantation AT olearyj roleofdonorspecifichlaalloantibodiesinlivertransplantation AT demetrisa roleofdonorspecifichlaalloantibodiesinlivertransplantation AT friedmanl roleofdonorspecifichlaalloantibodiesinlivertransplantation AT gebelh roleofdonorspecifichlaalloantibodiesinlivertransplantation AT halloranp roleofdonorspecifichlaalloantibodiesinlivertransplantation AT kirka roleofdonorspecifichlaalloantibodiesinlivertransplantation AT knechtles roleofdonorspecifichlaalloantibodiesinlivertransplantation AT mcdiarmids roleofdonorspecifichlaalloantibodiesinlivertransplantation AT shakeda roleofdonorspecifichlaalloantibodiesinlivertransplantation AT terasakip roleofdonorspecifichlaalloantibodiesinlivertransplantation AT tinckamk roleofdonorspecifichlaalloantibodiesinlivertransplantation AT tomlanovichs roleofdonorspecifichlaalloantibodiesinlivertransplantation AT woodk roleofdonorspecifichlaalloantibodiesinlivertransplantation AT woodlee roleofdonorspecifichlaalloantibodiesinlivertransplantation AT zacharya roleofdonorspecifichlaalloantibodiesinlivertransplantation AT klintmalmg roleofdonorspecifichlaalloantibodiesinlivertransplantation |